Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Héctor Álvarez Duarte"'
Publikováno v:
Revista Cubana de Investigaciones Biomédicas, Vol 27, Iss 1, p 0 (2008)
Con el objetivo de evaluar las posibilidades de un análisis cualitativo simple de la curva fotopletismográfica AC para diagnosticar la insuficiencia arterial de miembros inferiores, se compararon los registros obtenidos en las extremidades de 289 p
Externí odkaz:
https://doaj.org/article/11c8c4867b184d8180382519ad1bfb31
Autor:
Jorge Berlanga-Acosta, Ernesto López-Mola, Marianela Garcia-Siverio, Gerardo Guillen-Nieto, Pedro Lopez-Saura, Calixto Valdez-Pérez, Isabel Puentes-Madera, William Savigne-Gutierrez, Héctor Álvarez-Duarte, Norberto Miranda-Espinosa, Ana J Mir-Benítez, Diana García del Barco, Yssel Mendoza-Mari, María D Martínez-Espina, Ariana Garcia-Ojalvo, Nelvys Subiros-Martinez, Luis Herrera-Martínez
Publikováno v:
Biotecnología Aplicada, Vol 29, Iss 4, Pp 208-217 (2012)
Type 2 diabetes mellitus comprises a group of non-communicable metabolic diseases with an expanding pandemic magnitude. Diabetes predisposes to lower extremities ulceration and impairs the healing process leading to wounds chronification. Diabetes al
Externí odkaz:
https://doaj.org/article/f8ce551d27954685a708fa8f96cb519f
Autor:
Milagros García Mesa, Héctor Álvarez Duarte, Miriam Mahía Vilas, José Hernández Carretero, Martha M. Fors López
Publikováno v:
Journal of Tissue Viability. 20:67-72
Background De Marco Formula (DMF) is a new procaine chemical combination of Procaine HCl and polyvinylpyrrolidone. A prospective randomized controlled clinical trial demonstrated that infected ischemic diabetic foot treatment with DMF for 52 days as
Autor:
José Hernández Carretero, Héctor Álvarez Duarte, Miriam Mahía Vilas, Martha M. Fors López, Milagros García Mesa
Publikováno v:
Journal of Tissue Viability. 19:116-122
Background A study has found that major amputations are necessary on 69% of ischemic diabetic foot patients treated with conventional therapy. An uncontrolled study of 31 patients showed that only 33% needed major amputation after treatment with conv